Definium Therapeutics, Inc. Proceeds from Common Stock Issued
Definium Therapeutics, Inc. (DFTX) reported Proceeds from Common Stock Issued of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfCommonStock · last filed 2026-02-26
- Definium Therapeutics, Inc. proceeds from issuance of common stock for the quarter ending 2025-12-31 was $0.00.
- Definium Therapeutics, Inc. proceeds from issuance of common stock for the quarter ending 2025-09-30 was $0.00.
- Definium Therapeutics, Inc. proceeds from issuance of common stock for the quarter ending 2024-12-31 was $0.00, a 100.00% decline year-over-year.
- Definium Therapeutics, Inc. proceeds from issuance of common stock for the quarter ending 2024-09-30 was $0.00, a 100.00% decline year-over-year.
- Definium Therapeutics, Inc. proceeds from issuance of common stock for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- Definium Therapeutics, Inc. proceeds from issuance of common stock for fiscal 2024 was $984.00K, a 86.93% decline from fiscal 2023.
- Definium Therapeutics, Inc. proceeds from issuance of common stock for fiscal 2023 was $7.53M, a 82.20% decline from fiscal 2022.
- Definium Therapeutics, Inc. proceeds from issuance of common stock for fiscal 2022 was $42.30M, a 48.37% decline from fiscal 2021.
| Period end | Proceeds from Issuance of Common Stock 3 month | Proceeds from Issuance of Common Stock 6 month | Proceeds from Issuance of Common Stock 7 month | Proceeds from Issuance of Common Stock 9 month | Proceeds from Issuance of Common Stock 12 month |
|---|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $0.00 derived: sum of 2 quarters · filed 2026-02-26 | $0.00 10-K · filed 2026-02-26 | ||
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $0.00 10-Q · filed 2025-11-06 | |||
| 2025-06-30 | $0.00 10-Q · filed 2025-07-31 | ||||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $0.00 derived: sum of 2 quarters · filed 2026-02-26 | $984.00K 10-K · filed 2026-02-26 | ||
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $984.00K 10-Q · filed 2025-11-06 | |||
| 2024-06-30 | $984.00K 10-Q · filed 2025-07-31 | ||||
| 2023-12-31 | $2.59M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | $5.67M derived: sum of 2 quarters · filed 2025-03-06 | $6.95M derived: sum of 3 quarters · filed 2025-03-06 | $7.53M 10-K · filed 2025-03-06 | |
| 2023-09-30 | $3.09M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $4.36M derived: sum of 2 quarters · filed 2023-11-02 | $4.94M 10-Q · filed 2023-11-02 | $5.67M derived: sum of 4 quarters · filed 2024-02-28 | |
| 2023-06-30 | $1.27M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $1.86M 10-Q · filed 2023-08-03 | $2.59M derived: sum of 3 quarters · filed 2024-02-28 | ||
| 2023-03-31 | $583.00K 10-Q · filed 2023-05-04 | $1.31M derived: sum of 2 quarters · filed 2024-02-28 | |||
| 2022-12-31 | $730.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $42.30M 10-K · filed 2024-02-28 | |||
| 2022-09-30 | $41.57M 10-Q · filed 2023-11-02 | ||||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | -$4.00K derived: sum of 2 quarters · filed 2023-03-09 | -$189.00K derived: sum of 3 quarters · filed 2023-03-09 | $81.92M 10-K · filed 2023-03-09 | |
| 2021-09-30 | -$4.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$189.00K derived: sum of 2 quarters · filed 2022-11-10 | $81.92M 10-Q · filed 2022-11-10 | ||
| 2021-06-30 | -$185.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $81.93M 10-Q · filed 2022-08-11 | |||
| 2021-03-31 | $82.11M 10-Q · filed 2022-05-16 | ||||
| 2020-12-31 | $71.99M 10-K · filed 2022-03-28 | ||||
| 2019-12-31 | $9.90M 10-K · filed 2022-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cronos Group Inc. (CRON) | $1.223B | ||
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B |